Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY) announced today positive results from the Phase III ...

This is the web version of STAT’s special newslette r from the annual meeting of the American Society of Oncology. For more ...

Genentech’s short film draws on the experiences of multiple families caring for children with hemophilia A, seeking to ...

Genentech will close its cancer immunology research department, and unit head and renowned cell biologist Ira Mellman, who has been with the company for 17 years, will depart in the coming months.

Genentech has announced an investment exceeding $700m to establish its first East Coast manufacturing facility in North ...

Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today positive final results from the overall ...

Genentech CEO Alexander Hardy, in an interview with STAT, explained that in the world that existed prior to the Inflation Reduction Act’s passage last year, drugmakers were incentivized to get ...

Genentech's ranibizumab injection (Susvimo) has received FDA approval for the treatment of diabetic retinopathy. The ...

How Genentech and other drug makers are stepping up the game in how they interact with patients. As Sawsan Zakaria and other spinal muscular atrophy patients made their way along the fashion show ...

Orionis Biosciences, a privately held company, announced a second multi-year collaboration with Genentech, a member of the Roche Group (OTCQX:RHHBY). The goal of this partnership is to discover ...

With a background in biochemistry, Erica Taylor admits her route into marketing is not common, but it has given her a unique ...